Lippert, Jörg
172  results:
Search for persons X
?
2

Model‐Informed Drug Development: Steps Toward Harmonized Gu..:

Marshall, Scott ; Ahamadi, Malidi ; Chien, Jenny...
Clinical Pharmacology & Therapeutics.  114 (2023)  5 - p. 954-959 , 2023
 
?
4

Model‐informed bridging of rivaroxaban doses for thrombopro..:

Willmann, Stefan ; Ince, Ibrahim ; Ahsman, Maurice...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  8 - p. 1111-1121 , 2022
 
?
6

List of contributors:

, In: Principles of Translational Science in Medicine,
Azam, Faisal ; Bax, Heather J. ; Berzofsky, Jay A.... - p. xiii-xv , 2021
 
?
7

CKD subpopulations defined by risk‐factors: A longitudinal ..:

Ramaswamy, Rajagopalan ; Wee, Soon Nan ; George, Kavya...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  11 - p. 1343-1356 , 2021
 
?
8

Population pharmacokinetic analysis of rivaroxaban in child..:

Willmann, Stefan ; Coboeken, Katrin ; Zhang, Yang...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  10 - p. 1195-1207 , 2021
 
?
9

Computational biology and model-based approaches in transla..:

, In: Principles of Translational Science in Medicine,
 
?
10

A generic framework for the physiologically‐based pharmacok..:

Frechen, Sebastian ; Solodenko, Juri ; Wendl, Thomas...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  6 - p. 633-644 , 2021
 
?
11

Data‐driven personalization of a physiologically based phar..:

Fendt, Rebekka ; Hofmann, Ute ; Schneider, Annika R. P....
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  7 - p. 782-793 , 2021
 
?
 
?
13

NT‐proBNP Qualifies as a Surrogate for Clinical End Points ..:

Schmitt, Walter ; Rühs, Hauke ; Burghaus, Rolf...
Clinical Pharmacology & Therapeutics.  110 (2021)  2 - p. 498-507 , 2021
 
?
 
1-15